The drug industry won a reprieve from sweeping tariffs announced by President Donald Trump on Wednesday, though it could be short-lived as the White House moves forward with plans for future levies on pharmaceutical imports.
As US President Donald Trump laid out a wave of new tariffs that will take average levies to their highest in more than a century, he drew cheers and laughs from aides and supporters in the White House Rose Garden. For economists, markets and the rest of the world, there was very little to celebrate.
A former minor-league baseball player and his father were charged with fraud over the failure of an Arizona sports complex that cost municipal bondholders more than $280 million.
SpaceX, United Launch Alliance and Jeff Bezos’ Blue Origin won billions of dollars in contracts to loft the Pentagon’s most-sensitive satellites over several years.
PVH Corp., the owner of the Calvin Klein and Tommy Hilfiger brands, is expecting sales growth to be flat or slightly positive this year, outpacing analysts’ expectations.